Sign up to save your podcasts
Or
Share 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
View all episodes
By STAT
4.5
303303 ratings
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
More shows like The Readout Loud
View all
Planet Money
30,975 Listeners
a16z Podcast
1,011 Listeners
Odd Lots
1,769 Listeners
How I Built This with Guy Raz
30,269 Listeners
The Daily
111,073 Listeners
KFF Health News' 'What the Health?'
485 Listeners
The Long Run with Luke Timmerman
124 Listeners
Tradeoffs
386 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
146 Listeners
Biotech Hangout
11 Listeners
Ground Truths
45 Listeners
Money Stuff: The Podcast
368 Listeners